A Novel Combination Oral Agent to Treat Acne Vulgaris
| Status: | Completed |
|---|---|
| Conditions: | Acne, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 13 - 60 |
| Updated: | 4/2/2016 |
| Start Date: | November 2010 |
| End Date: | September 2011 |
| Contact: | H G Berlin, ESQ |
| Email: | garyberlin17@hotmail.com |
| Phone: | 561-739-5252 |
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
The purpose of this study is to evaluate a novel, combination product for the treatment of
acne vulgaris in females
acne vulgaris in females
Inclusion Criteria:
- Healthy females 13 years of age or older
- Non-pregnant, non-lactating females
- Signed written informed consent form
- Must be able to understand and be willing to follow all study instructions
- Have a clinical diagnosis of acne vulgaris
Exclusion Criteria:
- Female subjects who are pregnant or nursing
- Any concomitant dermatologic condition that may affect outcome measures
- Concurrent use of any other medication to treat acne vulgaris
- Have a history or clinical evidence of any other active acute or chronic medical
disease or condition considered by the principal investigator as unsuitable for the
study
- Are currently using any other investigational agent or device
- Have participated in any other clinical study within 90 days prior to enrollment
- Employees or family members of sponsor or research site
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials